Khiron Life Sciences Reports Second Quarter 2022 Financial Results
- Monday, August 29, 2022, 7:01
- Finance
- Add a comment
Reports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target markets Recorded its lowest ever Adjusted EBITDA loss in Q2 2022 at ($2.3) million, down 30% quarter-over-quarter and 39% year-over-year Net loss of…
About the Author
adminasapcorp has written 39016 stories on this site.